BOSTON, March 18, 2025 /PRNewswire/ — Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today presents on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington’s Disease to members of the Huntington’s Disease Youth Organization (HDYO), at the biannual HYDO International Congress in Prague, […]
The post Skyhawk Therapeutics Secures Spotlight at HDYO International Congress 2025 first appeared on Business News Week.
Comments are closed